Metabesity Congress 2017

A unique and important meeting, The World Congress on Targeting Metabesity (Metabesity2017), will take place 30-31 October 2017 in London, UK.

A unique and important meeting, The World Congress on Targeting Metabesity (Metabesity2017), will take place 30-31 October 2017 in London, UK.

The term Metabesity expresses the idea, for which scientific evidence has been accumulating over recent decades, that major non-communicable diseases of aging (such as diabetes, cardiovascular diseases, neurodegenerative diseases and cancer) may have common metabolic roots, and thus may be susceptible to common solutions. 

Metabesity2017 aims to serve as a call to action and generate a roadmap for a tractable “moonshot” program to extend healthy aging by targeting these major illnesses of old age.

The congress will assemble world-renown scientists with their peers in policy, industry, government and other disciplines to map a way forward that will involve innovative, large-scale coordination between the public and private sectors, and will have other major medical, policy and ethical ramifications.

The co-chairs of the congress are Lawrence Steinman, M.D., George A. Zimmermann Professor of Pediatrics, Neurology and Neurological Sciences at Stanford University, and G. Alexander Fleming, M.D., Founder and Executive Chairman of Kinexum, and a former senior FDA reviewer.

Confirmed speakers to date include scientists who are members of the Boards of Roche and of the Novo Nordisk Foundation, as well as the Chair of the Nobel Assembly that selects the recipients of the Nobel Prize in Medicine or Physiology.

Other speakers that have been invited include senior officials of health authorities in the US and UK

The hope of the co-chairs is that Metabesity could become a ‘Davos-like’ annual gathering that will build upon the call to action and roadmap to actual implementation of scientific knowledge through public and private policies to help people live longer, healthier lives.  The conference website is